Unknown

Dataset Information

Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.


ABSTRACT:

Objectives

To assess the risk of acute and post-acute adverse events after SARS-CoV-2 infection in children and adolescents in Denmark and to evaluate the real world effectiveness of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) among adolescents.

Design

Cohort study.

Setting

Nationwide Danish healthcare registers.

Participants

All Danish people younger than 18 years who were either tested for SARS-CoV-2 using reverse transcriptase polymerase chain reaction (RT-PCR) or vaccinated with BNT162b2 to 1 October 2021.

Main outcome measures

Risk of hospital admissions (any hospital contact of ≥12 hours); intensive care unit (ICU) admissions; serious complications, including multisystem inflammatory syndrome in children (MIS-C), myocarditis, and neuroimmune disord

SUBMITTER: Kildegaard H 

PROVIDER: S-EPMC8995669 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature